BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14248907)

  • 1. [COMMON ANTIGEN GROUPS OF SENDAI AND NEWCASTLE DISEASE VIRUS (NDV)].
    NEURATH AR; ZUFFA A
    Z Immunitats Allergieforsch; 1964 Jun; 126():381-91. PubMed ID: 14248907
    [No Abstract]   [Full Text] [Related]  

  • 2. FACTORS WHICH AFFECT THE RELEASE OF NEWCASTLE DISEASE AND SENDAI VIRUSES FROM INFECTED ALLANTOIC CELLS.
    BARRY RD
    J Gen Microbiol; 1965 May; 39():229-38. PubMed ID: 14324967
    [No Abstract]   [Full Text] [Related]  

  • 3. SELECTIVE HEMAGGLUTINATION OF MYXOVIRUSES.
    LOBODZINSKA M; KIDANKIEWICZ T; SKURSKA Z
    Arch Immunol Ther Exp (Warsz); 1964; 12():164-72. PubMed ID: 14166656
    [No Abstract]   [Full Text] [Related]  

  • 4. INVESTIGATIONS ON THE VARIABILITY OF THE PATHOGENICITY OF NEWCASTLE DISEASE VIRUS (NDV). IV. INFLUENCE OF BACTERIAL INFECTION (PASTEURELLA MULTOCIDA) AND PARASITIC INVASION (ASCARIDIA GALLI).
    ZEBROWSKI L; MAJEWSKA H; BYCZYNSKI Z
    Acta Microbiol Pol (1952); 1964; 13():205-10. PubMed ID: 14211341
    [No Abstract]   [Full Text] [Related]  

  • 5. ANTIVIRAL AND COFACTOR-LIKE ACTIVITIES OF SOME DEXTRAN SULFATES.
    STYK B; HANA L; RADA B
    Acta Virol; 1963 Sep; 7():480. PubMed ID: 14062341
    [No Abstract]   [Full Text] [Related]  

  • 6. THE GROWTH AND NEUTRALIZATION OF NEWCASTLE DISEASE VIRUS IN BHK21 TISSUE CULTURES.
    FRENCH EL; STGEORGE TD
    Aust J Exp Biol Med Sci; 1965 Jul; 43():371-80. PubMed ID: 14343497
    [No Abstract]   [Full Text] [Related]  

  • 7. ASSOCIATION OF MYXOVIRUSES WITH AN ADENOSINE DIPHOSPHATASE/ADENOSINE TRIPHOSPHATASE/AS REVEALED BY CHROMATOGRAPHY ON DEAE-CELLULOSE AND BY DENSITY GRADIENT CENTRIFUGATION.
    NEURATH AR; SOKOL F
    Z Naturforsch B; 1963 Dec; 18():1050-2. PubMed ID: 14117575
    [No Abstract]   [Full Text] [Related]  

  • 8. STUDIES ON MYXOVIRUS YUCAIPA: ITS CLASSIFICATION AS A MEMBER OF THE PARAMYXOVIRUS GROUP.
    DINTER Z; HERMODSSON S; HERMODSSON L
    Virology; 1964 Mar; 22():297-304. PubMed ID: 14127827
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of different methods of inactivation of Newcastle disease virus and avian influenza virus in egg fluids and serum.
    King DJ
    Avian Dis; 1991; 35(3):505-14. PubMed ID: 1835374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHARACTERIZATION OF "SOLUBLE" ANTIGENS DERIVED FROM CELLS INFECTED WITH SENDAI AND NEWCASTLE DISEASE VIRUSES.
    ROTT R; WATERSON AP; REDA IM
    Virology; 1963 Dec; 21():663-5. PubMed ID: 14100620
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of a novel Newcastle disease virus (NDV) neutralization test based on recombinant NDV expressing enhanced green fluorescent protein.
    Chumbe A; Izquierdo-Lara R; Calderón K; Fernández-Díaz M; Vakharia VN
    Virol J; 2017 Nov; 14(1):232. PubMed ID: 29169354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Destruction of virus hemagglutination inhibitor of egg-white by Newcastle disease virus.
    MCCOLLUM WH; BRANDLY CA
    Proc Soc Exp Biol Med; 1955 Oct; 90(1):158-62. PubMed ID: 13273383
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular and antigenic characteristics of Newcastle disease virus isolates from domestic ducks in China.
    Wu W; Liu H; Zhang T; Han Z; Jiang Y; Xu Q; Shao Y; Li H; Kong X; Chen H; Liu S
    Infect Genet Evol; 2015 Jun; 32():34-43. PubMed ID: 25725159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune and antibody response of a newly isolated lentogenic strain of Newcastle disease virus in poultry.
    Malik BS; Dhawedkar RG
    Avian Dis; 1970 May; 14(2):400-3. PubMed ID: 5427241
    [No Abstract]   [Full Text] [Related]  

  • 15. EFFECT OF FACTORS DESTROYING CELL RECEPTORS ON FORMATION OF INCOMPLETE PARTICLES OF NEWCASTLE DISEASE VIRUS (NDV).
    MAJEWSKA H
    Acta Microbiol Pol (1952); 1964; 13():195-204. PubMed ID: 14211340
    [No Abstract]   [Full Text] [Related]  

  • 16. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
    Miller PJ; King DJ; Afonso CL; Suarez DL
    Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemagglutination with Newcastle disease virus (NDV).
    FLORMAN AL
    Proc Soc Exp Biol Med; 1947 Apr; 64(4):458-63. PubMed ID: 20239458
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune response to oil-emulsion vaccines with single or mixed antigens of Newcastle disease, avian influenza, and infectious bronchitis.
    Xie ZX; Stone HD
    Avian Dis; 1990; 34(1):154-62. PubMed ID: 2157390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRESENCE OF A NEWCASTLE DISEASE-LIKE AGENT IN CHICKEN EMBRYO CELLS: A PRELIMINARY NOTE.
    FONTAINE MP; FONTAINE M; CHABAS D; BRION A
    Avian Dis; 1965 Feb; 9(1):1-7. PubMed ID: 14253991
    [No Abstract]   [Full Text] [Related]  

  • 20. Chimeric Newcastle disease virus-vectored vaccine protects chickens against H9N2 avian influenza virus in the presence of pre-existing NDV immunity.
    Liu J; Xue L; Hu S; Cheng H; Deng Y; Hu Z; Wang X; Liu X
    Arch Virol; 2018 Dec; 163(12):3365-3371. PubMed ID: 30187143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.